Type 2 & other diabetes

International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL

Diabetes CarePublished Pooled individual participant data analysis of the ADVANCE, TECOS and EXSCEL trials

Authors' conclusion

Postcoronary case fatality was substantially higher in Asia, Central and Eastern Europe, and South America and Africa compared with Western countries and higher in low- and middle-income countries compared with high-income countries.

Study context

Population
ADVANCE, TECOS and EXSCEL participants with T2D who had within-trial major coronary (fatal or nonfatal MI or sudden cardiac death) or cerebrovascular (fatal or nonfatal stroke) eventspooled ADVANCE, TECOS, EXSCEL
Participants
40,563 participants
Comparison
Geographic regions and country income levels vs reference
Outcome
Case fatality: death at the time or within 30 days of a major coronary or cerebrovascular event
Follow-up
Within 30 days
Methodological detailsindividual participant data meta-analysis, logistic regression, adjusted for previous cardiovascular events and risk factors
  • Individual participant data meta-analysis
  • Logistic regression
  • Adjusted for previous cardiovascular events and risk factors

Pooled result

As reported in the abstract

Postcoronary case fatality
Estimate (95% CI)
Asiavs Western Europe, North America, or Australia and New Zealand
aOR 3.31(2.32–4.72)
Central and Eastern Europevs Western Europe, North America, or Australia and New Zealand
aOR 2.78(2.11–3.66)
South America and Africavs Western Europe, North America, or Australia and New Zealand
aOR 2.84(1.71–4.73)
Low- and middle-incomevs High-income
OR 3.07(2.41–3.92)
Major coronary events
2,574

Further pooled results

Case fatality after major cerebrovascular event · within 30 days

Major cerebrovascular events
1,247
Did not differ by geographic region or income group

Original publication

International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL. Diabetes Care. Published 28 August 2025. doi:10.2337/dc25-0541

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.